Nonhormonal rehabilitation of reproductive system in women after surgical treatment nodular fibrocystic breast disease

Authors

  • Ю. Я. Присташ Lviv National Medical University

DOI:

https://doi.org/10.18370/2309-4117.2013.14.64-68

Keywords:

breasts, mastopathy, fi brocystic breast disease, prolactin, hyperprolactinemia, Mastodynon

Abstract

Common benign breast disease is mastopathy, occurring in 20–60% of women, most aged 20–40 years. Surgical treatment of nodular forms of mastopathy does not eliminate the main cause of the disease – hormonal disorders (hyperprolactinemia, relative hyperestrogenemia). After the operation should be carried out conservative treatment aimed at eliminating the causes of dishormonal disorders and normalizes hormonal balance in the body, and to avoid recurrence.
Currently, there is a wealth of clinical experience in the use of conservative treatment of dishormonalbreast disease herbal drugMastodynon.Pathogeneticeff ects of Mastodynon, its property gently regulate hormonal homeostasis through its infl uence on the hypothalamic-pituitary-ovarian axis lead to improvement of breast tissue and node prevention in patients with fi brocystic breast disease.

Author Biography

Ю. Я. Присташ, Lviv National Medical University

PhD, assistant professor of Oncology and Medical Radiology Department

References

Smolanka II, Ljashenko AО Fibrocysticbreastdisease // Women Doctor, № 1, 2007, p. 16.

Zaitsev VF Surgeontacticatthenodal lesions ofbreast / VF Zaitsev, TA Nikolaienko, SV Sugak // Act ualproblemsofclinicalmedicine. Mn., 1999. P. 35–36.

Vysotskaya IV, Letyagin VP, Kim EA Dishormonalmammarydysplasia // Mammalogy. – 2006. – № 2. – P. 9–12.

Andreeva EN, Ledneva EV Keyaspectsoftheetiologyandpathogenesis offi brocysticbreastdisease// Obstetricsand Gynecology. – 2002. – № 6. – P. 7–9.

Tagieva TT, Volobuev AI Mastodynonapplication in women withfi brocysticbreastdisease // HealthofUkraine. – 2002. – № 5.

Published

2013-11-12

Issue

Section

Tumors and pretumoral pathology